Yüklüyor......
Prevention of preterm birth by progestational agents: what are the molecular mechanisms?
OBJECTIVE: Clinically, vaginal progesterone (VP) and 17 alpha-hydroxyprogestreone caproate (17P) have been shown to prevent preterm birth (PTB) in high risk populations. We hypothesize treatment with these agents may prevent PTB by altering molecular pathways involved in uterine contractility or cer...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3581865/ https://ncbi.nlm.nih.gov/pubmed/23433326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2013.01.020 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|